According to a filing submitted to the U.S. Securities and Exchange Commission (SEC), GlaxoSmithKline has decided to terminate its collaboration and licensing agreement with Alector Inc., with the termination to take effect on January 2, 2027.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This move marks the imminent end of the collaboration between the two companies on specific research and development projects.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Sector Update: Financial
MT newswire•2026/09/29 19:45
30-Year Treasury Yield Rises to 5.594% -- Data Talk
Dow Jones•2026/09/29 19:35
Kalshi Weighs $1B Funding Round at Nearly $40B Valuation as It Expands
CoinEdition•2026/09/29 19:27
Correction to Jersey Mike's Subs Rating
Dow Jones•2026/09/29 19:09
Crypto prices
MoreBitcoin
BTC
$83,551.94
+0.23%
Ethereum
ETH
$2,689.78
+0.58%
Tether USDt
USDT
$0.9996
+0.00%
BNB
BNB
$754.91
-0.99%
XRP
XRP
$1.49
+0.24%
USDC
USDC
$1
-0.00%
Solana
SOL
$118.76
+0.28%
TRON
TRX
$0.3350
-0.33%
Zcash
ZEC
$1,399.75
-4.15%
Hyperliquid
HYPE
$85.34
-2.91%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now